Dermatology Times
OCTOBER 21, 2023
Dawn Merritt, DO, and Mark Lebwohl, MD, took the stage to explain the history of CSU, the prevalence of testing and food avoidance, approved treatments, and monitoring treatment improvement for the condition.
Dermatology Times
OCTOBER 21, 2023
The goal of Arron et al’s study was to determine if the 40-GEP test could identify high-risk cSCC patients who would benefit from ART in controlling metastatic disease progression.
Dermatology Times
OCTOBER 21, 2023
The positive outcomes observed in these cases underscore the potential for these products to revolutionize the way dermatology clinicians address visible signs of facial aging.
Dermatology Times
OCTOBER 21, 2023
Keep up with the latest headlines in dermatology from the past week, including the creation of a dermatology outreach organization centered in Detroit, a tropical skin disease endemic in parts of the US, and more.
Dermatology Times
OCTOBER 21, 2023
The pharmacokinetic profile of APG777, characterized by an extended half-life, increased exposure, and reduced clearance compared to lebrikizumab, is promising for patients with IL-13-driven diseases.
Dermatology Times
OCTOBER 21, 2023
Although still in its early stages, the program showcases the potential value of tangible interactions between dedicated navigators and patients in enhancing support and continuity of care.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
OCTOBER 21, 2023
Catch up on coverage from the third day of the 2023 Fall Clinical Dermatology Conference.
Dermatology Times
OCTOBER 21, 2023
Shah is presenting alongside a panel of leading experts at Fall Clinical 2023.
Expert insights. Personalized for you.
90 
Let's personalize your content